Protein O-GlcNAcylation in cardiovascular diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiology

Background:

• O-GlcNAcylation is a dynamic post-translational modification regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA).
• This modification occurs in the cytoplasm, nucleus, and mitochondria, influencing cellular processes.
• O-GlcNAcylation is implicated in cardiovascular disease (CVD) pathogenesis, with its role being complex and context-dependent.

Purpose of the Study:

• To review the intricate relationship between protein O-GlcNAcylation and cardiovascular disease (CVD).
• To elucidate the molecular mechanisms underlying O-GlcNAcylation's impact on cardiac function.
• To explore O-GlcNAcylation as a potential therapeutic target for cardiovascular events.

Main Methods:

• Literature review focusing on studies investigating O-GlcNAcylation in cardiovascular contexts.
• Analysis of existing research on the enzymes OGT and OGA in relation to heart disease.
• Synthesis of data on metabolic and signaling pathways affected by O-GlcNAcylation.

Main Results:

• O-GlcNAcylation exhibits a dual role in CVD: acute elevation is protective, while chronic elevation is detrimental to cardiomyocytes.
• Altered O-GlcNAcylation levels can lead to significant metabolic imbalances and affect cardiovascular function.
• Mechanisms involve the regulation of transcription, energy metabolism, and signal transduction pathways.

Conclusions:

• The role of O-GlcNAcylation in CVD is controversial, depending on the duration and level of modification.
• Understanding these complex mechanisms is crucial for developing novel therapeutic strategies for cardiovascular diseases.
• Targeting O-GlcNAcylation pathways may offer a new avenue for treating cardiovascular events.